Proactive Investors - Run By Investors For Investors

Johnson Matthey shares rise as underlying full-year sales slightly beat expectations, dividend up 7%

Tthe FTSE 100-listed automotive catalysts manufacturer saw its underlying sales at constant currency rates grow by 7% to £3.846bn, with 8% growth in the second half
Catalyst manufacturing
Johnson Matthey is hiking its final dividend by 7% to 80p, up from 75p a year earlier

Johnson Matthey PLC (LON:JMAT) saw its shares rise on Thursday after the specialty chemicals firm saw its underlying full-year sales come in slightly ahead of expectations and it hiked its dividend by 7% reflecting confidence in the outlook.

In results for the year ended 31 March 2018, the FTSE 100-listed automotive catalysts manufacturer saw its underlying sales at constant currency rates grow by 7% to £3.846bn, slightly ahead of the company’s expectations, with 8% growth posted in the second half.

READ: Johnson Matthey to take £50mln hit as it settles engine lawsuit

The firm reported a 1% rise in underlying pre-tax profit to £486mln, up from £482mln a year earlier, with operating profit up 2% to £525mln.

Robert MacLeod, Johnson Matthey’s chief executive, commented: “We have made significant progress in executing our strategy and delivered a financial performance in line with our expectations at the start of the year.”

He added: “In the coming year we expect mid to high single-digit growth in operating performance.

“The changes we are making as we continue to develop our business give me confidence in our strategy to deliver, over the medium term, mid to high single-digit EPS CAGR, expanding ROIC to 20% and, as a result, a progressive dividend."

The group proposed an increase in the final dividend of 7% to 80p, up from 75p a year earlier, which, the CEO said, “reflects our confidence in the prospects of Johnson Matthey.”

In early morning trading, Johnson Matthey shares were up 2.6% at 3,486p.

“Great deal going on under the bonnet”

Richard Hunter, head of markets at Interactive Investor commented “There is a great deal going on under the bonnet at Johnson Matthey, with its cash generative ability allowing further reinvestment into new technologies.”

He added: “There will, however, continue to be bumps in the road along the way. The Return on Capital figure moved in the wrong direction, down to 16.4%, making the 20% target rather more of a stretch.”

“Nonetheless,” Hunter concluded, “the potential is clear for the company and the initial positive reaction to the results builds on a 10% spike in the share price over the last three months alone.

“During the last year, the shares have added 8.3%, outperforming the wider FTSE100 which has risen 2.1%, and this update is likely to consolidate the general market view of the shares as a buy for the long term.”

View full JMAT profile View Profile

Johnson Matthey Timeline

Related Articles

February 18 2019
The firm specialises in using nanomaterials, including graphene, to improve or enhance the properties of products such as plastics or ceramics
May 24 2019
In May, Itaconix received its first purchase order from chemical firm Nouryon for its personal care polymer following the signing of an exclusive supply agreement in February
Grape bunches
April 03 2019
Eden Research's first product Mevalone, a grape fungicide which is used to target the botrytis disease, is currently being sold throughout the southern EU zone and Kenya

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use